Martha Knight

2.0k total citations
68 papers, 1.6k citations indexed

About

Martha Knight is a scholar working on Molecular Biology, Analytical Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Martha Knight has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 32 papers in Analytical Chemistry and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Martha Knight's work include Chromatography in Natural Products (32 papers), Neuropeptides and Animal Physiology (19 papers) and Pharmacological Effects of Natural Compounds (16 papers). Martha Knight is often cited by papers focused on Chromatography in Natural Products (32 papers), Neuropeptides and Animal Physiology (19 papers) and Pharmacological Effects of Natural Compounds (16 papers). Martha Knight collaborates with scholars based in United States, China and Singapore. Martha Knight's co-authors include Kurt D. Hankenson, Carol A. Tamminga, Thomas N. Chase, Werner A. Klee, Yoichiro Ito, David J. Bill, Steven L. Cohen, James Shorter, Elizabeth A. Sweeny and Luca Steardo and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Martha Knight

64 papers receiving 1.6k citations

Peers

Countries citing papers authored by Martha Knight

Since Specialization

Citations

This map shows the geographic impact of Martha Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Knight more than expected).

Fields of papers citing papers by Martha Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Knight. The network helps show where Martha Knight may publish in the future.

Co-authorship network of co-authors of Martha Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Knight. A scholar is included among the top collaborators of Martha Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Knight. Martha Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Countercurrent chromatography research shaped by Yoichiro Ito 2025 ·Journal of Chromatography A ·Martha Knight	0
2	Review of Diabetes Mellitus in Relation to Pancreatic Cancer 2021 ·Özge Alper, (unknown), Martha Knight, Özgül M. Alper, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	R-spondin-2 is a Wnt agonist that regulates osteoblast activity and bone mass 2018 ·Bone Research ·Martha Knight, Kannan Karuppaiah, (unknown), Sarthak Mohanty, Robert L. Zondervan, Sheila M. Bell, Jaimo Ahn, Kurt D. Hankenson	102
4	Purification of R-phycoerythrin from Gracilaria lemaneiformis by centrifugal precipitation chromatography 2018 ·Journal of Chromatography B ·Dongyu Gu, (unknown), Fang Chen, Zhantong Wang, Ying Ma, Martha Knight, Yoichiro Ito	16
5	Isolation of sutherlandins A, B, C and D from Sutherlandia frutescens (L.) R. Br. by counter-current chromatography using spiral tubing support rotors 2017 ·Journal of Chromatography A ·Cuiping Chen, William R. Folk, (unknown), (unknown), Martha Knight	7
6	Mesenchymal Stem Cells in Bone Regeneration 2013 ·Advances in Wound Care ·Martha Knight, Kurt D. Hankenson	239
7	Spiral Countercurrent Chromatography 2013 ·Journal of Chromatographic Science ·Yoichiro Ito, Martha Knight, (unknown)	21
8	Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients 2012 ·Cell ·Morgan E. DeSantis, (unknown), Elizabeth A. Sweeny, Meredith E. Jackrel, (unknown), (unknown), Shilpa Vashist, Matthew Sochor, Martha Knight, James Shorter	136
9	Application of centrifugal precipitation chromatography and high‐speed counter‐current chromatography equipped with a spiral tubing support rotor for the isolation and partial characterization of carotenoid cleavage‐like enzymes in Enteromorpha compressa (L.) Nees 2011 ·Journal of Separation Science ·Susanne Baldermann, (unknown), Ziyin Yang, (unknown), Peter Fleischmann, Peter Winterhalter, Martha Knight, (unknown), Naoharu Watanabe	14
10	Spiral counter-current chromatography of small molecules, peptides and proteins using the spiral tubing support rotor 2011 ·Journal of Chromatography A ·Martha Knight, (unknown), (unknown), Adam D. Clayton, Aprile L. Pilon	16
11	Vortex counter-current chromatography 2010 ·Journal of Chromatography A ·Yoichiro Ito, (unknown), (unknown), (unknown), Martha Knight, (unknown)	10
12	Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet 2008 ·American Journal of Physiology-Heart and Circulatory Physiology ·Dinko Sušić, Xiaoyan Zhou, Edward D. Fröhlich, Howard Lippton, Martha Knight	57
13	Improved spiral tube assembly for high-speed counter-current chromatography 2008 ·Journal of Chromatography A ·Yoichiro Ito, (unknown), (unknown), Martha Knight, (unknown)	46
14	(Stearyl, Norleucine17) VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells 1997 ·Life Sciences ·Terry W. Moody, Julius Leyton, (unknown), Sonia B. Jakowlew, Kenji Takahashi, (unknown), Minsoo Koh, Mati Fridkin, Illana Gozes, Martha Knight	31
15	Separation and purification of peptides by high-speed counter-current chromatography 1995 ·Journal of Chromatography A ·Martha Knight, Mirela O. Fágárásan, Kazuyuki Takahashi, (unknown), Ying Ma, (unknown)	16
16	Purification of a synthetic myristylated peptide by counter-current chromatography 1991 ·Journal of Chromatography A ·Martha Knight, (unknown), Kazuyuki Takahashi, (unknown), Richard Kahn	6
17	Evidence for Distinct Endothelin Receptors in the Pulmonary Vascular Bed in vivo 1991 ·Journal of Cardiovascular Pharmacology ·Howard Lippton, Gordon Cohen, Martha Knight, Ivan F. McMurtry, (unknown), (unknown), Warren R. Summer, Albert L. Hyman	2
18	Direct evidence for an important species difference in the mechanism of 8‐OH‐DPAT‐induced hypothermia 1991 ·British Journal of Pharmacology ·David J. Bill, Martha Knight, (unknown), (unknown)	155
19	Chromatography of peptides on a multi-coil counter-current chromatograph 1989 ·Journal of Chromatography A ·Martha Knight, (unknown)	4
20	Reversed-phase preparative chromatography of [d-Ala1]peptide T amide 1988 ·Journal of Chromatography A ·Martha Knight, (unknown), Richard W. Perkins, Terrence R. Burke	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact